The application and integration of the best available research, clinical expertise, quality marks and patient preferences to ensure high-quality care in substance use disorders services.
Quality Assurance
Trust in Your Gut – Clinical Applications of Polyvagal Theory in Therapy and Relapse Prevention
Description: The Polyvagal Theory of Stephen Porges, PhD, has been with us for 25 years, but the practical application to therapy has been slow to develop.
Gender disparities in opioid treatment progress in methadone versus counselling
The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and...
High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centres with SBIRT services
Brief treatment (BT) or regular outpatient alcohol use or substance use disorder (SUD) treatment is a key element of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model. It can be an effective, short-term, and low...
Reporting treatment fidelity in behavioral tobacco treatment clinical trials: scoping review and measurement recommendations
Abstract Introduction: Adoption of rigorous standards for reporting treatment fidelity is essential for advancing discovery, validation, and implementation of behavioral treatments. Whereas the NIH Behavior Change Consortium (BCC) developed...
Chronic care treatment for smoking cessation in patients with serious mental illness: a pilot randomized trial
Background: Rates of smoking among those with serious mental illness (SMI) are two to three times higher than for the general population. Smoking is rarely addressed in mental health settings. Innovative outreach and treatment strategies...
Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life
Background: Smoking is still prevalent among people with substance use disorders. The objective of this study was to investigate the prevalence of smoking among patients in treatment for substance use disorders and to analyze the effect of...
Effectiveness of a digital alcohol moderation intervention as an add-on to depression treatment for young adults: study protocol of a multicentre pragmatic randomized controlled trial
Background: Depressive disorders and problematic drinking often co-occur, also among young adults. These co-occurring conditions are associated with various negative health outcomes compared to both conditions alone. Early intervention by...
Dame Carol Black's Independent Review of Drugs - Part 2
Collective Voice are delighted to welcome Dame Carol Black as the keynote speaker of our next webinar, presenting the findings from the second part of her Independent Review of Drugs.
Dame Carol's presentation will be followed by comments from Rosanna O'Connor, Interim Director, Health Improvement at Public Health England.
UNODC Keeps Supporting Quality Drug Treatment Service via Continuous Capacity Building
UNODC Regional Office for Central Asia supported regional training of trainers (ToT) on Course 11 “Enhancing Motivational Interviewing Skills”. This course is part of the Advanced Level of the Universal Treatment Curriculum for Substance...
